Alogliptin added to sulfonylurea therapy in patients with type 2 diabetes reduces HbA1c without increasing hypoglycemia

被引：0
|
作者：
Pratley, Richard
Kipnes, Mark
Fleck, Penny
Wilson, Craig
Mekki, Qais
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [1] Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without increasing weight gain or hypoglycemia
    Rosenstock, Julio
    Rendell, Marc
    Gross, Jorge
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2008, 57 : A132 - A133
  • [2] Alogliptin added to metformin therapy in patients with type 2 diabetes reduces HbA1c without changing weight or increasing gastrointestinal symptoms or hypoglycaemia
    Ellis, G.
    Fleck, P.
    Wilson, C.
    Mekki, Q.
    Nauck, M.
    DIABETOLOGIA, 2008, 51 : S343 - S344
  • [3] Addition of alogliptin to insulin therapy reduces HbA1c without increasing weight gain or hypoglycaemia in patients with type 2 diabetes
    Rendell, M.
    Rosenstock, J.
    Gross, J.
    Fleck, P.
    Wilson, C.
    Mekki, Q.
    DIABETOLOGIA, 2008, 51 : S37 - S38
  • [4] Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia
    Rosenstock, J.
    Rendell, M. S.
    Gross, J. L.
    Fleck, P. R.
    Wilson, C. A.
    Mekki, Q.
    DIABETES OBESITY & METABOLISM, 2009, 11 (12): : 1145 - 1152
  • [5] Impact of HbA1c and Sulfonylurea Use on Hypoglycemia in Type 2 Diabetes Mellitus
    Bron, Morgan
    Clements, Karen
    Taylor, Doug
    Emptage, Nicholas
    Hudgens, Stacie
    Dabbous, Omar
    DIABETES, 2010, 59 : A207 - A208
  • [6] Vildagliptin Combined With Insulin Reduces HbA1c Without Increasing Risk of Hypoglycemia and Weight Gain in Patients With Type 2 Diabetes Mellitus
    Lukashevich, Valentina
    Kozlovski, Plamen
    Foley, James
    Kothny, Wolfgang
    DIABETES, 2012, 61 : A254 - A254
  • [7] Dapagliflozin Added-On to Pioglitazone Reduces HbA1c and Mitigates Weight Gain with Low Incidence of Hypoglycemia in Type 2 Diabetes
    Rosenstock, Julio
    Vico, Marisa
    Wei, Li
    Salsali, Afshin
    List, James
    DIABETES, 2011, 60 : A270 - A270
  • [8] Effects of alogliptin on the ratio of glycated albumin to HbA1c in patients with type 2 diabetes mellitus
    Masumoto N.
    Otsuki H.
    Iwakawa S.
    Inada S.
    Goya K.
    Sho H.
    Suzuki S.
    Kurebayashi S.
    Hashimoto K.
    Koga M.
    Diabetology International, 2017, 8 (2) : 212 - 217
  • [9] A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes
    Bron, Morgan
    Wilson, Craig
    Fleck, Penny
    DIABETES THERAPY, 2014, 5 (02) : 521 - 534
  • [10] A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes
    Morgan Bron
    Craig Wilson
    Penny Fleck
    Diabetes Therapy, 2014, 5 : 521 - 534
12345